ObjectiveTo compare the pediculicidal activity of Ovide lotion and its active ingredient, 0.5% malathion, with Nix and its active ingredient, 1% permethrin, in permethrin-resistant head lice.DesignIn vitro pediculicidal product and active ingredient comparison. The presence of knockdown resistance–type mutations (T929I and L932F) was validated by DNA sequencing.SettingUniversity of Massachusetts-Amherst; University of Miami School of Medicine, Miami, Fla; Plantation and Homestead, Fla; and Mathis, Tex.Other ParticipantsLice were collected in 3 geographical regions within the United States and in Yamburara, Ecuador, from healthy but infested individuals.InterventionWithin 3 to 6 hours of collection, lice were given a blood meal, exposed to products or active ingredients, and observed at regular intervals.Main Outcome MeasuresPercent mortality of lice at regular intervals after exposure to products or active ingredients and presence of T929I and L932F mutations.ResultsSouth Florida lice exhibited a significantly slower mortality response to permethrin compared with susceptible Ecuadorian lice. Ovide and malathion killed permethrin-resistant lice faster than Nix or permethrin. The presence of T929I and L932F in permethrin-resistant south Florida lice was confirmed by DNA sequencing. The population of Texas lice from Mathis was slightly resistant to permethrin and included 13% with resistant genotypes.ConclusionsThe presence of the T929I and L932F mutations was confirmed by DNA sequencing in lice collected from children in south Florida that were resistant to the pediculicidal effects of permethrin and the leading permethrin-based head lice product, Nix. Malathion resistance was not observed in this study. The data also show that Ovide killed these same permethrin-resistant head lice approximately 10 times faster than permethrin or Nix.PEDICULOSIS, CAUSED by the human head louse (HL) Pediculus capitis,is the most prevalent parasitic infestation in children from the United States.Infestations continue to be reported in the United Statesand in other countries such as those of the United Kingdom (UK),Israel,the Czech Republic,and Argentinadespite the many over-the-counter, self-treatment medications available today. In the United States, consumer (nonprescription) treatment products are almost exclusively limited to those that contain the natural botanical active ingredients, the pyrethrins (eg, RID [Pfizer Inc, New York, NY], A-200 shampoo [Hogil Pharmaceutical Corp, Purchase, NY], and Pronto [Del Laboratories, Farmingdale, NY]), or those that contain the synthetic pyrethroid permethrin (eg, Nix [Pfizer/Warner-Lambert, Morris Plains, NJ]), as the active ingredients. These products have been previously reported to be highly effective in the treatment of infestations.It is well established in the published literaturethat resistance to permethrin exists in certain locations. In the United States, resistance to permethrin has been found in lice from children in Brookline and Cambridge, Mass; Chicopee and Holyoke, Mass; Boise, Idaho; and Plantation, Fla.Although resistance to malathion has been reported in the UK,none has been reported in the United States to date.Lee et alreported that US lice were resistant to permethrin and also exhibited knockdown resistance (kdr) in behavioral assays. Knockdown resistance is associated with increased nerve insensitivity and is similar to the kdr noted for DDT, the pyrethrins, and the pyrethroids reported originally in the housefly, Musca domestica.Two point mutations (T9291 and L932F) have been found to be associated with permethrin-resistant lice from Florida, Massachusetts, and Bristol, England, but not found in permethrin-susceptible lice from Panama.The T9291 mutation functions as a kdr-type mutation in the diamondback moth, Plutella xylostella.Recently, both mutations have been identified in lice throughout the UK and substantiate their importance in kdr.A recently reintroduced prescription treatment (1999), Ovide lotion (Medicis Pharmaceutical Corporation, Phoenix, Ariz), is a pediculicidal product that contains 0.5% pharmaceutical-grade malathion as the active ingredient in a special base. Meinking et alrecently reported that Ovide has superior pediculicidal and ovicidal activity on both susceptible and permethrin-resistant lice compared with the leading permethrin- and lindane-based products. These investigators concluded that Ovide killed permethrin-resistant lice and that these lice were not resistant to malathion.The purpose of the present study was to confirm and extend the findings of Meinking et al.Standard mortality bioassays determined comparative mortality profiles for both the Nix and Ovide products and their active ingredients. In addition, DNA sequencing determined whether the mutations associated with permethrin resistance were present and what influence they had on mortality.METHODSHUMAN HEAD LOUSE POPULATIONSThe Ecuador test population (EC-HL) was obtained from over 50 children in Yamburara, Ecuador (obtained by D.T.). They had never been exposed to pesticides, including permethrin and malathion, and were considered pediculicide susceptible. A mixed population of all stages and eggs were overnight expressed to the University of Massachusetts-Amherst and placed into a temporary colony fed on humans.The south Florida population (SF-HL) was collected from over 30 infested children in Plantation and Homesteadand are permethrin resistant.The Texas population (TX-HL) was obtained from a single heavily infested child (42 lice were obtained) from Mathis, Tex (obtained by L.B.). All collections and administration of informed consent forms were carried out using protocols previously approved by the institutional review board of the University of Massachusetts-Amherst.IN VITRO MORTALITY BIOASSAYSAfter collections, the EC-HL were transported to the Pesticide Toxicology Laboratory, Department of Entomology, University of Massachusetts-Amherst; the FL-HL to the Field Epidemiology Survey Team Laboratory; and the TX-HL to a temporary field laboratory in Mathis. All lice were given a blood meal prior to initiation of mortality bioassays by feeding on the investigator's hand.Filter paper and contact bioassays were used to determine lethality of 1% permethrin, 0.5% malathion, Nix (ingredients: 1% permethrin, balsam Canada, cetyl alcohol, citric acid, FD&C yellow #6 fragrance, hydrolyzed animal protein, hydroxyethylcellulose, polyoxyethylene 10 cetyl ether, propylene glycol, stearalkonium chloride, water, isopropyl alcohol, methylparaben, propylparaben) and Ovide shampoo (ingredients: 0.5% malathion, terpineol, dipentene and pine needle oil in 78% isopropyl alcohol). Filter paper disks (Whatman No. 1) were dipped for 10 seconds into 1% (vol/vol [1 part 10% permethrin in acetone to 9 parts acetone]) permethrin in acetone, 0.5% (vol/vol) malathion in acetone, or Ovide and were subsequently air dried in a dark fume hood for 4 hours. Disks were likewise dipped into Nix for 1 minute and dried in a dark fume hood for 24 hours owing to the slow drying characteristics of this product. Disks were also dipped into neet acetone, dried, and used as nontreatment controls.The bioassay procedure was conducted according to Lee et alexcept that mixed developmental stages (first, second, and third instars and adults) were examined. Log time vs logit mortality regressions were performed (POLO PC; LeOra Software, Berkeley, Calif, 1987) to determine lethal time 50% (LT50) values. To determine a susceptible or resistant phenotype following 1% permethrin exposure, the lethal time 95% (LT95) value of the insecticide-susceptible EC-HL was used. Survival beyond the calculated 7.6 hour value of this susceptible strain was used to assess permethrin resistance on a phenotypic basis. The use of timed bioassays at a single dose rather than multiple doses at a single time point is becoming a standard procedure for the assessment of resistance.We have chosen the same concentration that is used in the commercial products for both permethrin and malathion because this is how lice are actually exposed to the active ingredient (at a single concentration over a set time interval). The speed in which permethrin and malathion kills susceptible lice vs the resistant lice is therefore germane in the determination of resistance. Comparisons of the mortality responses due to different test materials were made using the maximum log-likelihood ratio test, which tests the hypothesis of equality of slopes and intercepts of the logit regressions (P= .05 [POLO PC]).DETERMINATION OF THE T929I AND L932F MUTATIONSTo determine whether a correlation exists between increased survivorship (due to resistance) and an increasing frequency of kdr-type mutations (T929I and L932F) for permethrin resistance,genomic DNA was extracted from individual SF-HL lice used in the mortality bioassays described previously, which were preserved in 95% ethanol. Extractions were performed using DNAzol (Molecular Research Center, Cincinnati, Ohio) with a slight modification (addition of 1% polyacryl carrier) to handle small samples according to the manufacturer's instruction. Genomic DNA was also obtained from a mixed population of permethrin-susceptible and -resistant lice from Mathis (TX-HL) and used as internal quality controls to assure that the DNA amplification and sequencing reactions were successful and capable of identifying lice with and without mutations. Two rounds of polymerase chain reaction (PCR) were performed with nested primers (BL5′Gn/3SP1 for first PCR and 5SP1L/3SP5N for the second PCR; Table 1) to amplify a DNA fragment (approximately 548 to 561 base pairs) containing the S4 to S6 regions of domain II of para-orthologous, voltage-sensitive sodium channel α-subunit gene of head lice. The presence or absence of kdr-type mutations (T929I or L932F) was determined by DNA sequencing (ABI 377XL; Applied Biosystems, Foster City, Calif) at the Automated DNA Sequencing Facility, University of Massachusetts-Amherst. Computer software, Gene Runner, Version 3.00 (Hastings Software, Bethesda, Md, 1994) was used to analyze and manage sequencing data.Table 1. PCR Primers for the Amplification of a Genomic DNA Fragment of the Para-Orthologous Sodium Channel α-Subunit Gene From the Human Head LouseNameSequenceBL5′Gn5′-GAGTCTTCAAATTGGCCAAATCGTG-3′3SP15′-CATTGTCAGCGGTGGGAGCAGA-3′5SP1L5′-CCACGTTAAATTTATTAATTTCAA-3′3SP5N5′-GATAAACTAGAGGAACCGAAATT-3′Abbreviation: PCR, polymerase chain reaction.RESULTSIN VITRO MORTALITY BIOASSAYSTreatment of the EC-HL with either 0.5% malathion or 1% permethrin resulted in significantly different and substantially reduced survival times compared with the acetone-treated EC-HL as judged by the maximum log-likelihood ratio test (χ22= 174.8 [P<.001] and χ22= 312.9 [P<.001], respectively) (Figure 1A). Malathion reduced the LT50value 9.0-fold and permethrin reduced the LT50value 5.2-fold compared with the acetone control (Table 2).Figure 1.Log time vs logit percent mortality regressions of human head louse populations from Ecuador (EC-HL) (A) and south Florida (Plantation and Homestead [SF-HL]) (B) treated with 1% permethrin (EC-HL, n = 45; SF-HL, n = 30), 0.5% malathion (EC-HL, n = 16; SF-HL, n = 30), or acetone (EC-HL, n = 30; SF-HL, n = 30) as a solvent control.Table 2. Lethal Time Values and Resistance Ratios From Human Head Louse Populations Treated With Various Pediculicidal Compounds and ProductsTreatmentsEC-HLSF-HLTX-HLRR*RR†LT50(95% CI), minLouse Sample, No.LT50(95% CI), minLouse Sample, No.LT50(95% CI), minLouse Sample, No.1% Permethrin187 (169-204)45577‡ (538-616)30268‡ (178-339)3220.127.116.11% Malathion107 (83-132)16129§ (79-197)30NANA1.2NANix (Pfizer/Warner-Lambert, Morris Plains, NJ)NANA551∥ (516-587)22NANANANAOvide (Medicis Pharmaceutical Corporation, Phoenix, Ariz)NANA57 (35-79)30NANANANAOvide vehicleNANA38 (30-46)15NANANANAControl965 (934-993)30748 (702-790)30NANANANAAbbreviations: CI, confidence interval; EC-HL, Ecuador test population; LT50, lethal time 50%; NA, not applicable; RR, mortality resistance ratio; SF-HL, south Florida test population; TX-HL, Texas test population.*RR = LT50(SF-HL)/LT50(EC-HL). †RR = LT50(TX-HL)/LT50(EC-HL).‡Significantly different from EC-HL (maximum log-likelihood test, P<.05).§Significantly not different from EC-HL (maximum log-likelihood test, P>.05).∥Significantly not different from 1% permethrin treatment in SF-HL (maximum log-likelihood test, P>.05).Treatment of the SF-HL with 0.5% malathion, likewise, resulted in significantly different and substantially reduced survival times compared with the acetone-treated SF-HL (χ22= 159.0 [P<.001]) (Figure 1B). Malathion reduced the LT50value 5.9-fold compared with no treatment (Table 2). Although treatment of the SF-HL with 1% permethrin also resulted in a significantly different response (χ22= 59.9 [P<.001]) (Figure 1B), the LT50value was not substantially reduced compared with the acetone treated SF-HL (1.3-fold, Table 2).The SF-HL (Figure 1B) exhibited significantly slower mortality response to 1% permethrin compared with the EC-HL (Figure 1A) (χ22= 218.5 [P<.001]). The mortality resistance ratio (RR) based on the LT50values of the SF-HL vs the EC-HL was 3.1 (Table 2) and confirmed that the SF-HL was resistant to permethrin.The mortality response of the SF-HL (Figure 1B) to 0.5% malathion, however, was not statistically different from the EC-HL (Figure 1A) (χ22= 2.7 [P= .26]). Although the LT50value of the SF-HL was slightly longer than for the EC-HL, the magnitude of difference was small (RR = 1.2) and their confidence limits were overlapped (Table 2). These results confirm that the SF-HL and EC-HL share a similar level of susceptibility to malathion and that the SF-HL lice were not resistant to this pediculicide.Comparatively, the mortality responses of the SF-HL to 0.5% malathion (Figure 1B) and Ovide (Figure 2) were significantly faster than when treated with 1% permethrin (Figure 1B) (χ22= 141.9 [P<.001] and χ22= 173.0 [P<.001], respectively) or with Nix (Figure 2) (χ22= 105.6 [P<.001] and χ22= 140.6 [P<.001], respectively). These findings indicate that both 0.5% malathion and Ovide are more efficient in killing permethrin-resistant lice in the SF-HL than 1% permethrin or Nix. The data also show that Ovide kills permethrin-resistant lice from the SF-HL approximately 10 times faster than 1% permethrin and Nix (Table 2).Figure 2.Log time vs logit percent mortality regressions of human head louse populations from south Florida (Plantation and Homestead [SF-HL]) treated with Nix (Pfizer/Warner-Lambert, Morris Plains, NJ) (n = 22) or Ovide (Medicis Pharmecutical Corporation, Phoenix, Ariz) (n = 30) compared with acetone control (n = 30).The mortality response of the SF-HL to Nix (Figure 2) is statistically the same as 1% permethrin (Figure 1B) (χ22= 1.8 [P<.4]). Similarly, the magnitude of the difference using the LT50values was small (LT50of 1% permethrin-treated SF-HL/LT50of Nix-treated SF-HL = 1.0) and their confidence limits were overlapped (Table 2).In the SF-HL, Ovide (Figure 2) exhibited a somewhat faster mortality response (2.3-fold, Table 2) compared with 0.5% malathion (Figure 1B) (χ22= 61.1 [P<.001]). Additionally, Ovide vehicle (Ovide without malathion) also elicits lethality. These results suggest that other ingredients (eg, isopropanol and terpenes) in Ovide may have pediculicidal activity. These differences may or may not be clinically meaningful but deserve further investigation.LINKAGE OF PERMETHRIN-RESISTANT PHENOTYPES AND KDR-TYPE MUTATIONSTwo populations were used to establish a linkage between increasing survivorship to 1% permethrin and increasing frequency of the 2 kdr-type mutations. The TX-HL was one of the most permethrin-susceptible US populations assayed to date as judged by its LT50value compared with that of the SF-HL (2.2-fold more susceptible, Table 2) and by its calculated RR vs the EC-HL (RR = 1.4; Table 2). Additionally, the overlap of its regression line with that of the permethrin-resistant SF-HL population only at the longer survival times would indicate a population that consists mostly of susceptible individuals with some highly resistant individuals (Figure 3). The SF-HL is resistant to permethrin (RR = 3.1; Table 2) and its regression line is not substantially different from that of its acetone control line (Figure 1B), which indicates a uniformly high tolerance to permethrin.Figure 3.Log time vs logit percent mortality regressions of human head louse populations from south Florida (Plantation and Homestead [SF-HL], n = 30) and Mathis, Tex (TX-HL, n = 33) treated with 1% permethrin.Using the LT95value of 7.6 hours from the EC-HL treated with 1% permethrin (Figure 1A) to assess the susceptible or resistant phenotype of individual lice (survival beyond 7.6 hours indicated resistance), it was determined that of the thirty-three 1%-permethrin–treated lice of the TX-HL, 15% (5) were resistant and 85% (28) were susceptible (Table 3). These same lice were genotyped using DNA sequence data, with 1 sample producing unreadable sequence (TPYE7). Only 13% (4/32) of these lice possessed the homozygous kdr-type mutations, and 87% (28/32) of the lice had no mutations or were heterozygous for these mutations (Table 3). It should be noted that kdr-type mutation has been widely determined to be inherited as a recessive factor and that heterozygous individuals are susceptible to DDT, the pyrethrins, and the pyrethroids in a variety of insect species.Of the lice that possessed the homozygous kdr-type mutations, all died at times greater than 7.6 hours (11-20 hours). Only 1 sample (TPYE4) had a mismatch between its phenotype (resistant) and its genotype (heterozygous susceptible). Using these criteria, we found a 97% agreement (31/32) between the phenotypic and the genotypic determinations.Table 3. Comparative Data of the Phenotype and Genotype of the Human Head Louse Population From Mathis, Tex, Following 1% Permethrin Mortality Bioassay (Phenotype) and DNA Sequencing Analysis (Genotype)PediculicideLouse Sample (N = 33)Time Died, hPhenotype* (S or R)Genotype†T929IL932F1% PermethrinTPYE118RRRTPYE2-311RRRTPYE48RHHTPYE56SHHTPYE63SHHTPYE75SUnreadable‡Unreadable‡TPYE85SHHTPYE95SSSTPYE10-115SHHTPYE12-145SSSTPYE15-175SHHTPYE186SHHTPYE19-206SSSTPYE21-226SHHTPYE23-276SSSYOON1-33SSSYOON43SHHYOON53SSSYOON620RRRAbbreviations: H, heterozygote allele; R, resistant allele; S, susceptible allele.*Determined by lethal time 95% value (7.6 hours) of 1% permethrin bioassay using the Ecuador test population. A louse that died in 7.6 hours or less was susceptible. A louse that died in more than 7.6 hours was resistant.†Genotype was assessed by actual DNA sequencing with T929 and L932 being susceptible and I929 and F932 being resistant genotypes.‡The DNA sequence cannot be determined owing to the high background in chromatogram.In contrast, it was phenotypically assessed that of the thirty 1%-permethrin–treated lice of the SF-HL (Figure 1B), 87% (26) were resistant and 13% (4) were susceptible (Table 4). Two samples, both of which were phenotypically resistant, failed to produced readable sequence (Per27 and 30). Genotypically, it was determined that in the SF-HL 96% (27/28) were resistant and 4% (1/28) were susceptible (Table 4). Using these criteria, we found an 86% (24/28) agreement between the phenotypic and genotypic determinations. These results indicate a strong correlation between the presence of the T929I and L932F mutations and survivorship beyond 7.6 hours in the 1%-permethrin bioassay, which is indicative of kdr-type permethrin resistance.Table 4. Comparative Data of the Phenotype and Genotype of the Human Head Louse Population From South Florida Following 1% Permethrin and Nix Mortality Bioassay (Phenotype) and DNA Sequencing Analysis (Genotype)PediculicideLouse SampleTime Died, hPhenotype* (S or R)Genotype†T929IL932F1% Permethrin (N = 30)Per113RRRPer213RSSPer3-412RRRPer5-611RRRPer7-107SRRPer118RRRPer12-159RRRPer16-2110RRRPer22-2611RRRPer2712RUnreadable‡Unreadable‡Per28-2912RRRPer3013RNANANix§ (N = 9)Nix1-315RRRNix412RUnreadableUnreadableNix512RRRNix6-810RRRNix99RRRAbbreviations: NA, not available (sample lost following bioassay); R, resistant allele; S, susceptible allele.*Determined by lethal time 95% value (7.6 hours) of 1% permethrin bioassay using the Ecuador population. A louse that died in 7.6 hours or less was susceptible. A louse that died in more than 7.6 hours was resistant.†Genotype was assessed by actual DNA sequencing with T929 and L932 being susceptible and I929 and F932 being resistant genotypes.‡The DNA sequence cannot be determined owing to the high background in chromatogram.§Pfizer/Warner-Lambert, Morris Plains, NJ.DETERMINATION OF THE FREQUENCY OF KDR-TYPE MUTATIONSLice were randomly selected from the SF-HL used in the mortality bioassays for Nix (Figure 2), 0.5% malathion (Figure 1B), and Ovide (Figure 2) and used for genotypic analysis. The LT50values determined from the log time vs logit mortality regression lines for the 9 lice randomly selected from the SF-HL treated with Nix (Table 4, bottom), the 5 lice treated with 0.5% malathion (Table 5, top), and the 7 lice treated with Ovide (Table 5, bottom) were statistically not different from the LT50values of their respective parent populations (Table 2) due to overlapping 95% confidence limits (552 [519-586] vs 642 [578-713], 129 [111-149] vs 227 [131-383], and 57 [51-64] vs 72 [55-92] minutes, respectively). Thus, the 3 randomly selected subpopulations used for sequencing were representative of their respective bioassayed parent populations.Table 5. Comparative Data of the Phenotype and Genotype of the Human Head Louse Population From South Florida Following 0.5% Malathion and Ovide Mortality Bioassay (Phenotype) and DNA Sequencing Analysis (Genotype)PediculicideLouse SampleTime Died, hPhenotype* (S or R)Genotype†T929IL932F0.5% MalathionMal1-45SRR(N = 5)Mal54SRROvide‡Ov1-31.7SRR(N = 7)Ov4-61.3SRROv71SRRAbbreviations: R, resistant allele; S, susceptible allele.*Determined by lethal time 95% value (5.1 hours) of 0.5% malathion bioassay using the Ecuador test population. A louse that died in 5.1 hours or less was susceptible. A louse that died in more than 5.1 hours was resistant.†Genotype was assessed by actual DNA sequencing with T929 and L932 being susceptible and I929 and F932 being resistant genotypes.‡Medicis Pharmaceutical Corporation, Phoenix, Ariz.Of the 9 randomly selected SF-HL lice treated with Nix, 100% (9/9) were phenotypically and 100% (8/8) were genotypically resistant, with 1 sample (Nix4) that was unreadable (Table 4). These results clearly establish the presence of kdr-type mutations and permethrin resistance in this subpopulation.Of the 5 randomly selected SF-HL lice treated with 0.5% malathion and the 7 lice treated with Ovide, 100% were genotypically resistant to permethrin (5/5 and 7/7, respectively) (Table 5). However, all were assessed to be phenotypically susceptible to 0.5% malathion and Ovide as judged by the LT95value of 0.5% malathion on the pediculicidal-susceptible EC-HL (5.1 hours, Figure 1A), and all died prior to the 7.6 hour value used to assess phenotypic resistance to permethrin, indicating that there is no cross-resistance to malathion in permethrin-resistant lice. Although based on limited numbers, these results show that, even in the presence of the kdr-type mutations and permethrin resistance, both 0.5% malathion and Ovide provided much faster kill times than 1% permethrin or Nix.COMMENTWe continue to confirm the presence of permethrin-resistant lice on individuals with pediculosis in the United States. Overall, the SF-HL is resistant to permethrin due to kdr-type mutations, but 0.5% malathion and Ovide kill these permethrin-resistant head lice in a manner not significantly different from that elicited by the insecticide-susceptible EC-HL. We were also able to demonstrate that a prescription-only product, Ovide, was able to kill the permethrin-resistant lice at a rate that was approximately 10 times faster than that observed for Nix.Our mortality bioassay data are in agreement with findings from 3 other independent studies.Although the overall conclusions are the same, the in vitro kill times observed in the present study are longer than those observed for both studies by Meinking et aland another conducted by Pollack et alowing to several differences between the in vitro mortality bioassay techniques used. In view of these differences, there is a clear need for standardizing the way in which pediculicidal effectiveness and resistance are evaluated in vitro. It must also be noted that the slower kill times for permethrin and Nix may not be clinically relevant as long as they also kill all the lice, albeit more slowly, in practice. This conundrum, however, can only be resolved by a clinical study that assesses the effectiveness of these products and the survivability of permethrin-resistant lice. The present work provides the means to carry out such a study.The combination of mortality bioassays and DNA sequence analysis confirms the original findings of Lee and coworkersthat the presence of kdr-type point mutations T929I and L932F is highly associated with permethrin resistance in field-collected head lice. The data presented also confirm and extend the recent findings by Meinking et althat Ovide is able to kill permethrin-resistant lice. This finding was expected because the 2 mutations associated with permethrin resistance in licedo not confer cross-resistance to the differing pharmacological and pediculicidal action of malathion in Ovide. Additionally, Ovide is not available except as a prescription product and has only been reintroduced to the market since 1999, which has limited its impact on louse populations. Since Ovide was able to kill lice many times faster than Nix and other permethrin-based products,its pediculicidal and ovicidal activitymake it an alternative treatment when permethrin resistance is a problem. Nevertheless, permethrin/malathion–dual resistant lice already exist in the UK and are a serious problem.Thus, surveillance for malathion resistance should be implemented if Ovide becomes the treatment of choice. Finally, our in vitro bioassay and genotyping data clearly indicate that permethrin-resistant head lice are established in the United States and warrant the need for additional clinical studies to ensure the continued efficacy of the currently available over-the-counter formulations that contain permethrin.NGGratzHuman Lice: Their Prevalence, Control and Resistance to Insecticides.WHO/CTD/WHOPES/97.8. Geneva, Switzerland: World Health Organization. 1997:1-61.TLMeinkingLSerranoBHardComparative in-vitro pediculicidal efficacy of treatments in a resistant head lice population in the United States.Arch Dermatol.2002;138:220-224.http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?db=m&form=6&Dopt=r&uid=11843643TLMeinkingPEntzelMEVillarMVicariaGLemardSLPorcelainComparative efficacy of treatment for Pediculus capitisinfestations: update 2000.Arch Dermatol.2001;137:287-292.http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?db=m&form=6&Dopt=r&uid=11255326TLMeinkingInfestations.Curr Probl Dermatol.1999;11(3):73-120.OChosidowScabies and pediculosis.Lancet.2000;355:819-826.http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?db=m&form=6&Dopt=r&uid=10711939JHPoorbaughHead lice infestation—treatment failures with 1% lindane (Kwell).Calif Morbidity.April 17, 1987. No. 14.KBrandenburgASDeinardJDiNapoliSJEnglenderJOrthoeferDWagner1% permethrin cream rinse vs 1% lindane shampoo in treating Pediculosis capitis.Am J Dis Child.1986;140:894-896.http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?db=m&form=6&Dopt=r&uid=2426940IFBurgessSPeockCMBrownJKaufmanHead lice resistant to pyrethroid insecticides in Britain [letter].BMJ.1995;311:752.http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?db=m&form=6&Dopt=r&uid=7549714AMDownsKAStaffordGCColesHead Lice: prevalence in schoolchildren and insecticide resistance.Parasitol Today.1999;15:1-4.http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?db=m&form=6&Dopt=r&uid=10234166AMDownsKAStaffordIHarveyGCColesEvidence for double resistance to permethrin and malathion in head lice.Br J Dermatol.1999;141:508-511.http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?db=m&form=6&Dopt=r&uid=10583056KYMumcuogluJHemmingwayJMillerPermethrin resistance in the head louse Pediculus humanus capitisfrom Israel.Med Vet Entomol.1995;9:427-432.http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?db=m&form=6&Dopt=r&uid=8541597JHemingwayJMillerKYMumcuogluPyrethroid resistance mechanisms in the head louse, Pediculus capitisfrom Israel: implications for control.Med Vet Entomol.1999;13:89-96.http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?db=m&form=6&Dopt=r&uid=10194754VRupesJMoravecJChmelaJLedvinkaJZelenkovaA resistance of head lice (Pediculus capitis) to permethrin in Czech Republic.Cent Eur J Public Health.1995;3:30-32.http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?db=m&form=6&Dopt=r&uid=7787823MIPicolloCVVanessaAACasidioJMassimoENZerbaLaboratory studies of susceptibility and resistance to insecticides in Pediculus capitis(Anoplura; Pediculae).J Med Entomol.1998;35:814-817.http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?db=m&form=6&Dopt=r&uid=9775614R JPollackAKiszewskiPArmstrongDifferential permethrin susceptibility of head lice sampled in the United States and Borneo.Arch Pediatr Adolesc Med.1999;153:969-973.http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?db=m&form=6&Dopt=r&uid=10482215SHLeeKSYoonMSWilliamsonMolecular analysis of kdr-like resistance in permethrin-resistant strains of head lice, Pediculus capitis.Pesticide Biochem Physiol.2000;66:130-143.AWFarnhamGenetics of resistance of house flies (Musca domesticaL) to pyrethroids, I: knockdown resistance.Pestic Sci.1977;8:631-636.THSchulerDMartinez-TorresAJThompsonToxicological, electrophysiological, and molecular characterization of knockdown resistance to pyrethroid insecticides in the diamondback moth, Plutella xylostella(L).Pestic Biochem Physiol.1998;59:169-182.FJOppenoorthBiochemistry and genetics of insecticide resistance.In: Kerkut GA, Gilbert LI, eds. Comprehensive Insect Physiology Biochemistry and Pharmacology. Oxford, England: Pergamon; 1985:731-773.HVaisMSWiliamsonPNUsherwoodThe molecular interaction of pyrethroid insecticides with insect and mammalian sodium channels.Pest Manag Sci.2001;57:877-888.http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?db=m&form=6&Dopt=r&uid=11695180AMRDownsMSWilliamsonKAStaffordGCColesA common mechanism of resistance to pyrethroids in head lice.Br J Dermatol.2002;114(S62):49.MGBrogdonJCMcAllisterInsecticide resistance and vector control.Emerg Infect Dis.1998;4:605-613.http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?db=m&form=6&Dopt=r&uid=9866736SHLeeJBDunnJMClarkDMSoderlundMolecular analysis of kdr-like resistance in a permethrin-resistant strain of Colorado potato beetle.Pestic Biochem Physiol.1999;63:63-75.DMSoderlundMolecular mechanisms of insecticide resistance.In: Sjut V, ed. Molecular Mechanisms of Resistance to Agrochemicals. Berlin, Germany: Springer Verlag; 1977:21-56.DCKnippleKEDoylePAMarsella-HerrickDMSoderlundTight genetic linkage between the kdr insecticide resistance trait and a voltage-sensitive sodium channel gene in the housefly.Proc Natl Acad Sci U S A.1994;91:2483-2487.http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?db=m&form=6&Dopt=r&uid=8146143MSWilliamsonIDenholmCABellALDevonshireKnockdown resistance (kdr) to DDT and pyrethroid insecticides maps to a sodium channel gene locus in the housefly (Musca domestica).Mol Gen Genet.1993;240:17-22.http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?db=m&form=6&Dopt=r&uid=8101963MFJTaylorDGHeckelTMBrownMEKrietmanBBlackLinkage of pyrethroid insecticide resistance to a sodium channel locus in the tobacco budworm.Insect Biochem Mol Biol.1993;23:763-775.http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?db=m&form=6&Dopt=r&uid=8397035KDongJGScottLinkage of kdr-type resistance and the para-homologous sodium channel gene in German cockroaches (Blatella germanica).Insect Biochem Mol Biol.1994;24:647-654.http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?db=m&form=6&Dopt=r&uid=7915170Corresponding author and reprints: J. Marshall Clark, PhD, Department of Entomology, University of Massachusetts, Amherst, MA 01003.Accepted for publication February 11, 2003.This study was supported by grant PHS 1 R01 AI45062-01A1 from the National Institutes of Health National Institute of Allergy and Infectious Diseases, Bethesda, Md, and by a grant-in-aid from Medicis Pharmaceutical Corporation, Phoenix, Ariz.We sincerely thank Lice Source Services, Inc, and Field Epidemiology Survey Team members for their assistance in louse collections and shipments.
JAMA Dermatology – American Medical Association
Published: Aug 1, 2003
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera